Table 2.
Results of the blood component analysis of the control and test groups after 3 weeks of treatment. ∗p < 0.05 compared with the control value.
| Index | Control | hEIF extract | ||
|---|---|---|---|---|
| 50 mg/kg | 100 mg/kg | 200 mg/kg | ||
| ALP (ng/mL) | 123.54 ± 4.81 | 126.19 ± 3.35 | 124.79 ± 4.28 | 119.89 ± 2.18 |
| Bone mineral density (g/cm2) | 0.090 ± 0.002 | 0.088 ± 0.003 | 0.088 ± 0.02 | 0.089 ± 0.003 |
| Calcium (mg/dL) | 2.33 ± 0.64 | 2.3 ± 0.59 | 2.38 ± 0.65 | 2.12 ± 0.50 |
| Estradiol (pg/mL) | 3.53 ± 0.21 | 3.54 ± 0.19 | 3.45 ± 0.35 | 3.12 ± 0.39 |
| Glucose (mg/dL) | 147.00 ± 24.24 | 167.80 ± 19.69 | 158.80 ± 19.40 | 175.80 ± 16.74 |
| IGF-1 (ng/mL) | 230.76 ± 12.12 | 197.91 ± 25.69 | 190.64 ± 20.17 | 185.82 ± 9.57 |
| IGFBP-3 (ng/mL) | 22.22 ± 1.05 | 19.65 ± 1.49 | 20.27 ± 0.45 | 21.1 ± 1.05 |
| LH (mIU/mL) | 292.33 ± 1.23 | 233.33 ± 1.63 | 293.4 ± 2.26 | 294.33 ± 2.13 |
| Osteocalcin (pg/mL) | 303.30 ± 4.79 | 306.90 ± 18.19 | 335.91 ± 14.46 | 326.83 ± 12.55 |
| Total cholesterol (mg/dL) | 62.50 ± 9.11 | 60.80 ± 7.26 | 56.60 ± 8.88 | 67.80 ± 10.83 |